Design and Process Development Services - Intelsius - A DGP Company | Cold Chain Packaging Solutions
Intelsius Logo
Certified by ISO Member of ISTA Certified by ISTA

Design and Process Development Services

Between 2011 and 2016, the projected growth of biologics is estimated at $52B from $140B to $192B. It is predicted that by 2016, eight of the top 10 and 27 of the top 50 best-selling global drug products will require 2 – 8°C cold-chain storage and handling. More than 70% of biologics and 100% of vaccines are temperature-sensitive.

At Intelsius, we understand the costs involved in developing the next life-saving treatment or cure for the human or animals populations.  Patient safety is our top priority too – that’s why we take your company, product and philosophy to heart in designing the most cost-effective, regulatory-compliant, temperature controlled solution for your payload.

With ATMOS™ (Analytical Thermal Modelling Software), a proprietary, predictive modelling software system designed by Intelsius, you could have a clear sense of direction for your temperature-controlled solutions in days.

ATMOS may save your company as much as 70% in packaging development time and costs. ATMOS requires significantly less time and energy than traditional environmental chamber testing.